CADQAS CIC supports and provides training in the interpretation of on-slide biomarkers either on site or elsewhere in UK or Europe, using our mobile pathology classroom.
Training courses offered to date include biomarker interpretation in Non-Small Cell Lung Cancer (e.g. ALK, SP263), Urothelial Carcinoma (SP142) and Triple Negative Breast Cancer (SP142). We also offer more general training courses on interpretation of diagnostic markers in lung and breast.
To be notified when future training courses are available please fill in the form below.
Please contact us if you would like to discuss the development of future training courses.
CADQAS CIC currently offers digital interpretive proficiency testing in the Middle East. We are in the process of expanding our portfolio and we are developing a number of pilot schemes for participants in other parts of the world. These will involve circulations of a small number of digital slides approximately twice a year for each biomarker.
Please use the form below to register your interest in hearing about more about our assessments.